Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1−/− mouse model of collagen VI-related myopathies

Sonia Calabrò; Leonardo Nogara; Yongzhi Jian; Manuel Valentin; Dario Bizzotto; Paola Braghetta; Loris Russo; Lisa Gambarotto; Bert Blaauw; Said Hashemolhosseini; Paolo Bonaldo; Matilde Cescon

doi:10.1002/ctm2.1688

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (7) : e1688 DOI: 10.1002/ctm2.1688

LETTER TO THE JOURNAL

Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1^−/− mouse model of collagen VI-related myopathies

Author information +

History +

PDF

Cite this article

Download citation ▾

Sonia Calabrò, Leonardo Nogara, Yongzhi Jian, Manuel Valentin, Dario Bizzotto, Paola Braghetta, Loris Russo, Lisa Gambarotto, Bert Blaauw, Said Hashemolhosseini, Paolo Bonaldo, Matilde Cescon. Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1^−/− mouse model of collagen VI-related myopathies. Clinical and Translational Medicine, 2024, 14(7): e1688 DOI:10.1002/ctm2.1688

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bonaldo P, Braghetta P, Zanetti M, et al. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet. 1998;7:2135-2140.

[2]	Merlini L, Angelin A, Tiepolo T, et al. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA. 2008;105:5225-5229.

[3]	Chrisam M, Pirozzi M, Castagnaro S, et al. Reactivation of autophagy by spermidine ameliorates the myopathic defects of collagen VI-null mice. Autophagy. 2015;11:2142-2152.

[4]	Gambarotto L, Metti S, Corpetti M, et al. Sustained oral spermidine supplementation rescues functional and structural defects in COL6-deficient myopathic mice. Autophagy. 2023;19(12):3221-3229.

[5]	Cescon M, Gregorio I, Eiber N, et al. Collagen VI is required for the structural and functional integrity of the neuromuscular junction. Acta Neuropathol. 2018;136:483-499.

[6]	Bartus RT, Bétourné A, Basile A, et al. β₂-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS). Neurobiol Dis. 2016;85:11-24.

[7]	McMacken G, Cox D, Roos A, et al. The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes. Hum Mol Genet. 2018;27:1556-1564.

[8]	McMacken GM, Spendiff S, Whittaker RG, et al. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome. Hum Mol Genet. 2019;28:2339-2351.

[9]	Lynch GS, Ryall JG. Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev. 2008;88:729-767.

[10]	Burke G, Hiscock A, Klein A, et al. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord. 2013;23:170-175.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.